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Abstract 
Synchrotron radiation is unique in its ability to deliver dose at high dose rates using kiloelectronvolt 
photons. We are investigating the use of Tantalum pentoxide (Ta2O5) nano-structured particles (NSPs) 
that are to date unexplored in synchrotron radiation fields as they have high atomic number (Z=73) are 
biocompatible and are therefore potential radio sensitizers. We exposed cell culture flasks containing 9L 
gliosarcoma tumour cells or Madin-Darby Canine Kidney (MDCK) non-tumour cells to the NSPs and 
treated the cells using a broad synchrotron beam (140 keV median energy; average dose rate of 50 Gy/s) 
at the Australian Synchrotron. We compare the results with those from similar cells treated using a 
conventional 150 kVp orthovoltage field (dose rate of 0.0127 Gy/s). The results reveal that the high dose-
rate synchrotron irradiation is more effective at killing the 9L cells relative to the MDCK cells than the 
orthovoltage irradiation. On the other hand, the NSPs are more effective at radiosensitizing the 9L cells 
compared to the MDCK cells in the orthovoltage radiation field, which is due to the NSP energy 
dependence in the kilovoltage energy range. Both the dose rate and energy spectrum need to be 
considered in future studies with synchrotron activation radiotherapy (SART). 
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Abstract. Synchrotron radiation is unique in its ability to deliver dose at high dose rates using 
kiloelectronvolt photons. We are investigating the use of Tantalum pentoxide (Ta2O5) nano-
structured particles (NSPs) that are to date unexplored in synchrotron radiation fields as they 
have high atomic number (Z=73) are biocompatible and are therefore potential radio sensitizers. 
We exposed cell culture flasks containing 9L gliosarcoma tumour cells or Madin-Darby Canine 
Kidney (MDCK) non-tumour cells to the NSPs and treated the cells using a broad synchrotron 
beam (140 keV median energy; average dose rate of 50 Gy/s) at the Australian Synchrotron. We 
compare the results with those from similar cells treated using a conventional 150 kVp 
orthovoltage field (dose rate of 0.0127 Gy/s). The results reveal that the high dose-rate 
synchrotron irradiation is more effective at killing the 9L cells relative to the MDCK cells than 
the orthovoltage irradiation.  On the other hand, the NSPs are more effective at radiosensitizing 
the 9L cells compared to the MDCK cells in the orthovoltage radiation field, which is due to the 
NSP energy dependence in the kilovoltage energy range. Both the dose rate and energy spectrum 
need to be considered in future studies with synchrotron activation radiotherapy (SART). 
1. Introduction 
High-Z nanoparticles (NPs) have been shown to improve the effectiveness of dose conformity to tumour 
tissue, particularly with macroscopic (broad beam) kilovoltage x-rays [1, 2]. The advantages of NPs, 
besides the primary benefit of enhancing local tumour radio-sensitivity, often include biocompatibility, 
permeability to cell membranes due to their nano-scale dimensions, and engineered abilities to 
specifically target certain tumours when coated. 
Tantalum pentoxide (Ta2O5) nano-structured ceramic particles (TaNSPs) were first reported as 
radio-sensitizers by Brown et al. 2014 [2]. Nano-structured ceramic particles (NSPs) have different 
characteristics and furthermore, aggregation properties than inert metal NPs. TaNSPs have a high atomic 
number (Z=73), are biocompatible, and its oxide component may provide a useful target for drug 
attachment.  
 Polychromatic synchrotron radiation has significantly high dose rates, of order of tens to hundreds 
of Gy per second. The effect of these beams on tumour tissue are not yet well documented, however it 
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is known that the inclusion of a high-Z targeting agents, such as platinum, gold, and iodine, can improve 
the treatment efficiency of synchrotron treatments, in their lower dose-rate monochromatic mode [3].  
 We aim to provide preliminary evidence of increased tumour response to high dose rates when 
compared to normal cells and characterise the ability of high-Z particles to selectively enhance 
synchrotron therapies, determining their efficacy toward Synchrotron Activation Radiotherapy (SART). 
2. Methods 
Tantalum pentoxide NSPs were synthesized according to the method detailed by Brown et al. [2] with 
sonication in an ultrasonic water bath, whilst suspended in PBS (phosphate buffered saline), for 2 hrs 
and mixed at 30 min intervals to promote the formation of smaller aggregates. 
  The NSPs were added to T12.5cm2 cell culture flasks containing monolayers of 9L gliosarcoma 
cancer cells (derived from rodent brain cells) or MDCK (Madin-Darby Canine Kidney) cells 24 hours 
before 90-100% confluence. Each cell culture was grown with complete Dulbecco’s modified eagle 
medium (c-DMEM) (DMEM supplemented with 10% fetal bovine serum (FBS) and 1% penicillin and 
streptomycin) and incubated at 37 °C and 5% (v/v) CO2. NSP concentrations ranging from 50-500 
µg/mL were added into flasks containing 5 mL DMEM.  
 Following 24 hrs of incubation with the NSPs, the cells were subcultured into 100 mm diameter 
petri dishes with 10 mL c-DMEM to evaluate NSP toxicity. Following 15 cell doubling times the cells 
were washed with 5 mL PBS (with calcium and magnesium ions) and fixed and stained with 5 mL of a 
(25% crystal violet and 75% ethanol) solution. Colonies consisting of no less than 50 cells were counted 
as surviving. The plating efficiency was evaluated as the ratio between the number of colonies present 
to the original cell seeding number. In this way, the impact of the irradiation or NSP toxicity was 
evaluated by comparing the plating efficiency of these treatments directly to the control plating 
efficiency and expressing this ratio as a normalized survival fraction.  
 For all experiments the flasks were irradiated when embedded in a 20 cm x 20 cm x 12 cm solid 
water phantom (RMI-457) with the cells at 2.5 cm depth. The irradiation field size was large enough to 
cover the whole flask in the case of the orthovoltage irradiations. For the synchrotron irradiations a step 
and shoot technique was utilized to create the irradiation field from the 1 mm x 12 mm intrinsic radiation 
field. The uniformity of the irradiation field was checked using EBT-3 film. The total dose was 
confirmed via a PTW PinpointTM ion chamber (model 31014).  
Flasks with or without 50 µg/mL of NSPs 
were irradiated in a vertical orientation at 
hutch 1B on the Imaging and Medical 
Beamline (IMBL) at the Australian 
Synchrotron, with a single dose (2 Gy), at 50 
Gy/sec, using a pink beam (4.65 mm Cu ex 
vacuo filtration). These results were 
compared with 2 Gy low dose-rate (LDR) 150 
kVp orthovoltage X-ray beam from a 
Nucletron Oldelft Therapax DXT 300 Series 
3 Orthovoltage unit at 0.76 Gy/min.  
The differences in energy spectra of these 
beams is shown in Figure 1. 
3. Results 
Preliminary observations of TaNSPs with a light microscope, show they are distributed quite 
homogeneously amongst MDCK flask, except for some aggregation outside the cells over time (Figure 
2). However, the TaNSPs tend to form clusters around the cell nucleus in the 9L gliosarcoma cells 
(Figure 3) due to the entrance of the TaNSPs into the cell and subsequent aggregation. 
 
Figure 1.    Photon beam energy spectra of 150 kVp 
orthovoltage X-rays (66 keV effective energy) and 
synchrotron pink beam (137 keV weighted average 
energy). 
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Toxicity of the Ta2O5 NSPs produce 
population survivals of 80-100%, in both cell 
lines without discrimination toward either cell 
line, as shown in Figure 4 for a range of NP 
concentrations.  
In the case of 9L cells, the results are very 
consistent with previously published data from a 
different production batch and indicates the 
excellent reproducibility of the production 
technique.   
This indicates that with TaNSPs, no toxic effect is 
acting on either cell line, and the cell survival 
following irradiation is purely dependent on the  





Figure 5. 9L cell survival following orthovoltage or 
synchrotron broad beam irradiation, with and without 
NSPs. 
 Figure 6. MDCK cell survival following orthovoltage 
or synchrotron broad beam irradiation, with and 
without NSPs. 
 
 Figures 5 and 6 highlight the effects of the different dose-rates on the cancer and normal cell lines 
respectively. Conventional 150 kVp orthovoltage treatment at 2 Gy LDR (low dose-rate) is compared 
with a synchrotron HDR (high dose-rate) broad beam. 
 Radioresistant 9L gliosarcoma cells appear to be more affected by the high dose rate than the 
MDCK cells. The orthovoltage treatment in comparison produces much greater 9L survival at 2 Gy than 
the synchrotron radiation. Radiosensitive MDCK in contrast, shows that there is insignificant difference 
between the orthovoltage treatment and HDR synchrotron treatment.  
 The addition of NSPs however, do not appear to significantly enhance the treatment of the 9L 




Figure 2.   Ta2O5 NSPs 
(black-brown) in MDCK. 
 Figure 3. Ta2O5 NSPs 
(black) in 9L cells. 
 
Figure 4. Intrinsic toxicity of Ta2O5 NSPs for 9L and 
MDCK cell lines. 
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enhancement expressed through an increase in cell death in the tumour cells. In the normal cells 
however, there is no therapy enhancement in either LDR or HDR treatment. We believe this is due to 
the difference in the nanoparticle uptake by the tumour line (more nanoparticles closer to the nucleus). 
 These results highlight the importance of considering the kV beam energy used for SART. NP 
dose enhancement is indeed highly energy dependent in the kilovoltage range.  
 Figure 7 shows that the 
150 kVp X-rays was precisely 
chosen to more directly target the 
photon absorption of the TaNPs 
relative to water and therefore 
optimize cell sensitization 
enhancement. The broad beam 
synchrotron radiation spectra 
would need further optimization 
and be lowered in energy to fully 
take advantage of dose 
enhancement by photoelectric 
effect on TaNSPs. 
4. Conclusion 
The inclusion of tantalum (V) oxide NSPs in kV beams is shown to improve tumour selectivity of the 
therapy.  We believe the improvement is related to the preferential uptake of the NSPs by the 9L 
gliosarcoma cells compared to the MDCK kidney cells, which seems to naturally occur. The selective 
uptake leads to a higher concentration of NSPs in the 9L cells compared to the MDCK cells. The higher 
concentration also leads to selective dose enhancement in 9L cells due to the high-Z nature of the NSPs 
acting to significantly increase the interaction cross section of the cells at low photon energies (40-100 
keV). Furthermore, the high dose rate of the synchrotron broad beam tends to produce greater effect on 
9L radioresistant tumorous cells. However, NSPs are less effective in the synchrotron broad field for 
either cell line in this case, due to the beam energy spectrum requiring further optimization to maximize 
the radiosensitization of the TaNSPs.  
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Figure 7. Comparison of beam energy spectra (grey) and ratio of total 
mass energy absorption coefficients of Ta2O5 to water (black) [4]. 
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